TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
LA JOLLA, Calif., April 15, 2009 /PRNewswire/ -- TorreyPines Therapeutics, Inc. today announced that it has hired Merriman Curhan Ford as its financial advisor to assist in the evaluation of strategic options, including the possible sale of the Company or its assets.
TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, and xerostomia. The company currently has three clinical stage product candidates: two ionotropic glutamate receptor antagonists and one muscarinic receptor agonist. Further information is available at.
Company contact:
Craig Johnson
Chief Financial Officer
TorreyPines Therapeutics, Inc.
858-623-5665 x 158
[email protected]
CONTACT: Craig Johnson, Chief Financial Officer, +1-858-623-5665, ext.158, , both of TorreyPines Therapeutics, Inc. [email protected]
Web site: http://www.tptxinc.com/